Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
12,939,536
-
Total 13F shares
-
17,136,981
-
Share change
-
+272,069
-
Total reported value
-
$87,562,375
-
Put/Call ratio
-
58%
-
Price per share
-
$5.11
-
Number of holders
-
71
-
Value change
-
-$1,565,828
-
Number of buys
-
39
-
Number of sells
-
24
Institutional Holders of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) as of Q3 2019
As of 30 Sep 2019,
Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,136,981 shares.
The largest 10 holders included
NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, Aisling Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and MARSHALL WACE, LLP.
This page lists
71
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.